No abstract available
Keywords:
chronic liver disease (CLD); cirrhosis; complications; fatty liver (see NAFLD); sarcopenia.
PubMed Disclaimer
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Sarcopenia, Frailty and Nutrition in Liver Diseases
References
-
-
Dasarathy S, Merli M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol. (2016) 65:1232–44. 10.1016/j.jhep.2016.07.040
-
DOI
-
PMC
-
PubMed
-
-
Anand A. Nutrition and muscle in cirrhosis. J Clin Exp Hepatol. (2017) 7:340–57. 10.1016/j.jceh.2017.11.001
-
DOI
-
PMC
-
PubMed
-
-
Feng Z, Zhao H, Jiang Y, He Z, Sun X, Rong P, et al. . Sarcopenia associates with increased risk of hepatocellular carcinoma among male patients with cirrhosis. Clin Nutr. (2020) 39:3132–9. 10.1016/j.clnu.2020.01.021
-
DOI
-
PubMed
-
-
Tantai X, Liu Y, Yeo YH, Praktiknjo M, Mauro E, Hamaguchi Y, et al. . Effect of sarcopenia on survival in patients with cirrhosis: a meta-analysis. J Hepatol. (2022) 76:588–99. 10.1016/j.jhep.2021.11.006
-
DOI
-
PubMed
-
-
Xu CQ, Mohamad Y, Kappus MR, Boyarsky B, Ganger DR, Volk ML, et al. . The relationship between frailty and cirrhosis etiology: from the functional assessment in liver transplantation (FrAILT) study. Liver Int. (2021) 41:2467–73. 10.1111/liv.15006
-
DOI
-
PMC
-
PubMed